Parkside Financial Bank & Trust’s Aerie Pharmaceuticals AERI Stock Holding History

Parkside Financial Bank & Trust’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-365	Closed	-$13K	–	1679
2018 Q4	$13K	Buy	365 +50	+16%	+$2.35K	﹤0.01%	699
2018 Q3	$19K	Hold	315	–	–	0.01%	625
2018 Q2	$21K	Buy	315 +86	+38%	+$4.81K	0.01%	585
2018 Q1	$12K	Hold	229	–	–	﹤0.01%	697
2017 Q4	$14K	Buy	229 +36	+19%	+$2.18K	0.01%	660
2017 Q3	$9K	Buy	193 +72	+60%	+$3.93K	﹤0.01%	760
2017 Q2	$6K	Buy	+121	New	+$5.63K	﹤0.01%	844

Other funds holding AERI

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

FCMI

Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

FCMI

Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Parkside Financial Bank & Trust's AERI Position: Q1 2019 in Review

Parkside Financial Bank & Trust sold out of Aerie Pharmaceuticals (AERI) in Q1 2019, closing a stake of 365 shares — an estimated $13K sold.

Parkside Financial Bank & Trust first reported a position in AERI in Q2 2017 and held it in 7 quarters. The position peaked at $21K in Q2 2018. 176 funds tracked by Wall St. Rank hold AERI as of Q1 2019.

Parkside Financial Bank & Trust reported no remaining Aerie Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
Parkside Financial Bank & Trust sold 365 Aerie Pharmaceuticals shares in Q1 2019, an estimated $13K.
Parkside Financial Bank & Trust first reported a position in Aerie Pharmaceuticals in Q2 2017 and held it in 7 quarters.
Parkside Financial Bank & Trust's Aerie Pharmaceuticals position peaked at $21K in Q2 2018.
176 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q1 2019.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2019, filed 1 May 2019.